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Background: The emerging concept is that microRNAs (miRNAs) play a central role in controlling stem cell
self-renewal and fate determination by regulating the expression of stem cell regulators. miR-125b, one of neuronal
miRNAs, recently was found to be necessary for neural differentiation of neural stem/progenitor cells (NS/PCs).
However, the other specific biological role of miR-125b in NS/PCs is little known. We used rat NS/PCs as a model
system to study the role of miR-125b in governing the behavior of NS/PCs.
Results: We report here the transfection of exogenous miR-125b inhibited proliferation of NS/PCs but promoted
differentiation and migration. Whereas anti-miR-125b had the opposite effect. Similar results were observed when
Nestin was knocked down by siRNA. Subsequently, we demonstrated that Nestin was a direct functional target of
miR-125b. MiR-125b downregulates the expression of luciferase through Nestin 3’untranslated region (3’-UTR), and
the regulation was abolished by mutations in the miR-125b binding site. MiR-125b targeted the 3'-UTR of Nestin and
reduced the abundance of Nestin at both mRNA and protein levels.
Conclusion: The results provided new insight into the function by which miR-125b modulates NS/PCs proliferation,
differentiation and migration. The data also indicated the regulatory role of miR-125b in NS/PCs might through the
suppression of Nestin expression.
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Neural stem/progenitor cells (NS/PCs) are the self-
renewing, multipotent cells that generate the main pheno-
types of the nervous system [1]. Neural stem/progenitor
cells (NS/PCs) have been studied extensively with the
hope of using them clinically. Recent studies have shown
that NS/PCs can act as promising and beneficial adjuncts
for therapy of neurological disorders including brain
trauma or spinal cord injuries, etc. Although the func-
tional properties of NS/PCs have been studied extensively,
the molecular mechanisms underlying neural stem cell
self-renewal, differentiation and migration are not fully
understood. To better understand the complex biological* Correspondence: jwdai@genetics.ac.cn
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reproduction in any medium, provided the orregulatory mechanisms of NS/PC will facilitate their clin-
ical application in future.
The discovery of miRNAs opens new possibilities in
terms of modulation of stem cells lineage commitment
and differentiation [2-4]. As a recently recognized class
of small noncoding RNA molecules, miRNAs are epi-
genetic modulators of mRNA degradation or protein
translation. Functional studies indicate that miRNAs
participate in the regulation of a number of cellular pro-
cesses, including development, proliferation, and differ-
entiation [5,6]. Modulating miRNA expression offers
new pathways for post-transcriptional gene regulation
and stem cell commitment. Several miRNAs have been
implicated in regulating self-renewal of neural stem cells
and neuronal fate specification [7]. Many studies demon-
strated that in vitro transient overexpression or inhib-
ition of brain-specific miRNAs in stem cells significantly. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Expression pattern of miR-125b and Nestin in NS/PCs
during differentiation. Expression pattern of miR-125b in NS/PCs
during differentiation quantified by real-time PCR using specific
Taqman primers. U6 was used as the internal control. In the
meantime, the expression level of Nestin was quantified by real-time
PCR during NS/PCs differentiation. GAPDH was used as the internal
control. Data represent mean±SD of three different experiments.
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Unlike messenger RNAs (mRNAs), miRNAs do not en-
code proteins, but rather bind mRNAs, regulating their
stability and translation into proteins. A single miRNA
can target hundreds of mRNAs resulting in very large
effects on the molecular constitution of cells. Thus, it is
vital to understand the unique functions and targets of
miRNA.
MiR-125b, a brain-enriched miRNA, is highly expressed
in the central nervous system (CNS), including the brain
and spinal cord. As a homolog of lin-4 (82% identical),
miR-125b is highly conserved from flies to humans (100%
identical) [9]. Upon neural differentiation, miR-125 as a
key player in the molecular cascade that contributes to the
irreversible commitment of pluripotent human stem cells
to the neural lineage [10]. Minh T et al. have also demon-
strated that the ectopic expression of miR-125b increases
the percentage of differentiated SH-SY5Ycells with neurite
outgrowth. Their report demonstrates that miR-125b is
important in regulating neuronal differentiation [11]. In
addition, it has also been demonstrated that miR-125b was
up-regulated during neural differentiation of embryonic
stem (ES) cells and embryo carcinoma (EC) cells. MiR-125
was identified as being involved in mechanisms governing
the repression of self-renewal in embryonic stem cells [12].
Taken together, these observations suggest that miR-125b
may act as an ancient regulatory switch for neuronal dif-
ferentiation in stem cells.
In the present study, we systematically investigated the
functions of miR-125b in NS/PCs and found new down-
stream target of miR-125b. We demonstrated the import-
ant role of miR-125b in coordinating the proliferation and
differentiation of NS/PCs using both knockdown and ec-
topic expression approaches. We also identified miR-125b
promotes migration during the early stages of neuronal dif-
ferentiation. Furthermore, our studies first demonstrated
that miR-125b suppresses the expression of Nestin by bind-
ing to the 3'-UTR of its mRNAs. As a widely employed
marker of multipotent neural stem cells, Nestin was
involved in a number of cellular processes, such as prolif-
eration, differentiation, migration [13,14]. Our study pre-
sented here revealed a previously undescribed link between
miR-125b and an essential stem cell regulator Nestin, iden-
tified it as a key target of miR-125b in NS/PCs.
Results
MiR-125b expression increases during neural stem cell
differentiation
NS/PCs may give rise to neural and neuronal pro-
genitor cells, it has been demonstrated that the dy-
namic changes in the expression of miRNA occurs
during neuronal differentiation. In order to under-
stand the role of miR-125b in the regulation of neuronal
differentiation, the expression pattern of miR-125b wasperformed by real-time PCR. The results showed that
the expression pattern of miR-125b was up-regulated in
a time-dependent manner with neural differentiation
proceeded suggesting that miR-125b may be involved in
differentiation of NS/PCs (Figure 1). Our results are coinci-
dent with previous reports indicating that miR-125b was
up-regulated during neural differentiation process [10-12].
MiR-125b Inhibits Nestin Expression by Binding to its
3’-UTR
Toward understanding the role of miR-125b involved in
regulating wide array of cellular process in NS/PCs, it is
therefore important to identify its target genes. Using the
MicroCosm Targets (formerly miRBase Targets), miR-125b
was identified to have a conserved target site in the 3’-UTR
of Nestin gene (Figure 2A). This program predicted a puta-
tive binding site for miR-125b in the Nestin 3’-UTR. MiR-
125b is highly conserved in vertebrates, and its mature nu-
cleotide sequence is 100% identical among several species
(Figure 2B). Although 3’-UTR sequences of Nestin are not
highly conserved in mammals, the putative binding sites for
miR-125b in Nestin are also found in both human and rat
(Figure 2B).
To further validated the interaction between miR-125b
and the Nestin 3’-UTR, the luciferase reporter system was
used. We constructed vectors containing wild-type or mu-
tant 3’-UTR of Nestin directly fused to the downstream of
the Firefly luciferase gene to verify that the putative miR-
125b binding site in the 3’-UTR of Nestin is responsible for
regulation by miR-125b (Figure 3A). The wild-type or mu-
tant vector of Nestin was cotransfected into Hela cells with
miR-125b mimics, miR-125b inhibitors, miR-125b NC
(negative control), miR-125b INNC (inhibitor negative
control). All of them are 2'-O-methyl (2'-O-Me)
modified RNA oligonucleotides chemically synthesized
Figure 2 Identification of a miR-125b target site in the 3’UTR of Nestin mRNA. (A) Putative binding sites of miR-125b in the Nestin 3’UTR
predicted by Microcosm Targets in different species. The nucleotide pairing of miR-125b and Nestin 3'-UTR. The vertical lines indicate perfect
pairing, while ":" indicates G-U wobble. (B) Conservation of miR-125b gene sequences between human and rat. Sequence alignment indicates
that miR-125b is 100% conserved in human and rat.
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tion is frequently used to protect oligoribonucleotides
from degradation in cultured cells. The transfection
efficiency was normalized by co-transfection with
Renilla reporter vector. When miR-125b mimics were
co-transfected with the Nestin reporter constructs,
luciferase activity was significantly suppressed com-
pared with cotransfection with miR-125b inhibitors,
NC and INNC. However, miR-125b mimics were un-
able to suppress luciferase expression with the mutant
Nestin 3’-UTR which the putative binding sites of
miR-125b were mutated (Figure 3B). Considering that
there still lies some complementary sequence to miR-
125b in the Nestin 3'-UTR besides the bases we have
mutated, the binding force between miR-125b and the
Nestin 3'-UTR was weakened but not eliminated.
Thus the luciferase expression in the mutated vector
group was a little suppressed compared to NC
and INNC group. Furthermore, we constructed the
3'-UTR vectors of ACTB and then cotransfected the
vector into Hela cells with miR-125b mimics and
inhibitors. The results indicated that miR-125b
mimics and miR-125b inhibitors had little effect on
luciferase expression with the ACTB 3’-UTR. These
experiments demonstrated that miR-125b interacts
directly with the binding site in Nestin 3’-UTR to
regulate luciferase reporter expression. Taken to-
gether, these findings indicated that Nestin is a direct
downstream target for miR-125b in NS/PCs.
Subsequently, we transfected miR-125b mimics, miR-
125b inhibitor, NC and INNC in NS/PCs to evaluate
whether Nestin mRNA and protein levels are directly
affected by the activation of miR-125b. Three days post
transfection, the Nestin mRNA and protein level were
analyzed by real-time PCR and Western blot (Figure 3C).Transfection with miR-125b mimics led to down-regulation
of Nestin mRNA and protein in NS/PC cells compared
with NC, whereas treatment with miR-125b inhibitor
induced the expression of Nestin increase in NS/PC cells
compared with INNC. Taken together, these experiments
support the hypothesis that Nestin is a direct target of miR-
125b and that miR-125b activation in NS/PCs elicits a de-
crease of Nestin protein.
MiR-125b inhibits NS/PCs proliferation
In an attempt to investigate whether miR-125b influ-
ences the proliferation of NS/PCs, we performed BrdU
labeling on rat NS/PCs after transfection of miR-125b
mimics, miR-125b inhibitor, NC and INNC. Considering
the tightly packed cells of a neurosphere are difficult to
transfect, the neurospheres were mildly trypsinized into
single cells and then seeded in polyornithine-laminin
coated 24-well plate. When cells reached 70% conflu-
ence, the miR-125b mimics, miR-125b inhibitor, NC and
INNC was transfected into the cells. The transfection ef-
ficiency was observed under the fluorescent microscope.
Transfection of NS/PCs with a FAM-labeled miR-125b
mimics indicated the high efficiency of transfection after
24 hours (Figure 4A). We also evaluated transfection ef-
ficiency by detecting the relative expression of miR-
125b. As expected, the intracellular level of miR-125b
was elevated by transfection of miR-125b mimics, and
was decreased by the transfection of miR-125b inhibi-
tors, showing that the cellular level of miR-125b could
be controlled by the transfection of miR-125b mimics
and miR-125b inhibitors (Figure 4B). Therefore we used
BrdU labeling to investigate the role of miR-125b in cell
proliferation, BrdU was added 16 hours prior to stem
cell harvesting and then stained with an anti-BrdU anti-
body. Immunostainings for BrdU show that the up-
Figure 3 MiR-125b suppresses the expression of the luciferase
reporter with Nestin 3’-UTR. (A) Schematic representation of the
constructs used in the luciferase reporter assay. The Nestin 3’-UTR
sequences containing the putative binding sites of miR-125b were
inserted into the the pGL3 luciferase reporter vector. Site-directed
mutagenesis was performed to mutate base pairs in the predicted
seed region targeted by miR-125b in the Nestin 3'-UTR. The mutant
binding site is underlined. (B) Luciferase assay was performed 72
hours after transfection using the Dual Luciferase. MiR-125b down-
regulated luciferase activities controlled by wild-type Nestin 3’UTR,
but did not affect luciferase activity controlled by mutant Nestin
3’UTR. The firefly luciferase activity was standardized to renilla
luciferase control. (**P < 0.01 vs. WT; *P < 0.05 vs. WT).The results are
means of three independent experiments±SD. (C) The expression
level of Nestin was analysed by qRT-PCR and the Western blot in NS/
PCs after transfection with miR-125b mimics, inhibitors, NC and
INNC. Bars show mean ± SD. All experiments were repeated three
times. * P < 0.05 vs. ctr, ** P < 0.01 vs. ctr.
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NS/PCs (Figure 5).
MiR-125b accelerates neural differentiation of NS/PCs
We next examined whether miR-125b influences the dif-
ferentiation of NS/PCs. The role of miR-125b in promot-
ing the differentiation of NS/PCs was demonstrated
further by staining for neuronal markers. Following
transfected with miR-125b mimics, miR-125b inhibitors,
NC, INNC, NS/PCs were cultured in differentiationconditions for 72 h. A significant decrease in the number
of Nestin-positive cells, Sox2-positive cells and Vimentin-
positive cells was found in NS/PCs transfected with
miR-125b mimics compared to control group (Figure 6A,
B, C). On the other hand, The percentage of Tuj1-
positive cells and Map2-positive cells in NS/PCs
transfected with miR-125b mimics were significantly
higher than control group (Figure 6D, E). The results
indicated that miR-125b over-expression enhances
rate of neuron differentiation, by contrast, knockdown
of miR-125b decreases rate of neuron differentiation
compared to the control. The results of real-time
PCR assays were well consistent with the results of
immunofluorescence indicating that overexpression of
miR-125b can independently increase the expression
of neuronal marker Tuj1 and Map-2 but decrease the
expression of Nestin, Sox2 and Vimentin (Figure 6F).
MiR-125b promotes the migration of NS/PCs
We used transwell migration assay to compare the
in vitro migratory capacities of NS/PCs among groups
transfected with miR-125b mimics, miR-125b inhibitor,
NC, INNC. Migration assays were performed after 72h
transfection. The percentage of migrated cells was nor-
malized to that of control cells. The results indicated
that overexpression of miR-125b led to a increase in cell
migration whereas knockdown of miR-125b led to a re-
duction in cell migration compared to control group in
NS/PCs (Figure 7).
Inactivation of Nestin not only reduces cell proliferation
but promotes neural differentiation and migration in
NS/PCs
Consistent with previous reports,we detected the relative
expression of Nestin mRNA decreased during neuronal dif-
ferentiation of NS/PCs in our studies (Figure 1). We con-
sidered the possibility of these biological changes induced
by miR-125b may be due to the down-regulation of Nestin.
For this purpose, we knocked down Nestin by RNAi and
assayed the effect of Nestin knockdown on cell prolifera-
tion, differentiation and migration in NS/PCs (Figures 5,6,7).
The results indicated that knockdown of Nestin reduced
cell proliferation and promoted neural differentiation and
migration in NS/PCs. The siRNA transfected NS/PCs
showed a similar biological behavior as observed in the cells
transfected with miR-125bmimics. Taken together, our data
suggested that miR-125b regulates neural stem cell prolif-
eration, differentiation and migration through targeting
Nestin expression.
MiR-125b regulate NS/PCs activities by targeting Nestin
In order to further validate the function of miR-125b in
NS/PCs activities via direct regulating Nestin, we trans-
fected NS/PCs with miR-125b mimics and the Nestin
Figure 4 Efficient transfection of miR-125b in NS/PCs. (A) At 24 post-transfection, transfection efficiency was assayed via fluorescent detection
of the 5’-FAM labelled miR-125b mimics in living NS/PCs. The high transfection efficiency was demonstrated using fluorescent microscopy. (B)
Real-time PCR was used to assess the efficiency of miR-125b transfection at 72 h after differential transfecton. U6 was included as a loading
control.
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The plasmid Nes-640-GFP was demonstrated to have a
longer half-life and more prominent protein levels inFigure 5 miR-125b inhibit NS/PCs proliferation. Cell proliferation was ev
images of NS/PCs stained with Brdu (green) and Hoechst dye (blue) 72 h a
growth medium until they were fixed and stained. Images were acquired b
positive cells at 72 h after transfection is shown. Bars show mean ± SD. All
vs. ctr.cells, which was kindly provided by John E. Erikssona
(Turku Center for Biotechnology, University of Turku
and Åbo Akademi University, Turku, Finland) (Sahlgrenaluated by bromodeoxy uridine (BrdU) incorporation. Representative
fter transfection. After transfection, the NS/PCs were maintained in
y a microscope using a 20 × objective lens. The percentage of BrdU-
experiments were repeated three times. * P < 0.05 vs. ctr, ** P < 0.01
Figure 6 (See legend on next page.)
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Figure 6 miR-125b accelerates neural differentiation. After transfection, the NS/PCs were maintained in differentiation medium. The
expression of the NS/PCs progenitor marker Nestin (A), Sox2 (B), Vinemetin (C) and the neuronal marker Tuj1 (D), Map2 (E) were detected by
immunofluorescence. Images were acquired by a microscope using a 20 × objective lens. Bars show mean ± SD. All experiments were repeated
three times. * P < 0.05 vs. ctr, ** P < 0.01 vs. ctr. (F) Real-time PCR analysis of Nestin, Sox2, Vinemetin, Tuj1 and Nestin expression in the same
differentiation time course 72 h after transfection. GAPDH was included as a loading control. Bars show mean ± SD. All experiments were
repeated three times. * P < 0.05 vs. ctr.
Cui et al. BMC Neuroscience 2012, 13:116 Page 7 of 13
http://www.biomedcentral.com/1471-2202/13/116et al., 2006). We demonstrated that exogenously expressed
Nestin could rescue the effect on NS/PCs proliferation, dif-
ferentiation and migration resulting by miR-125b mimics
(Figure 8). Furthermore, we determined to test whether de-
pletion of Nestin may weakened the role of miR-125b inhi-
bitors in NS/PCs. When Nestin was knocked down by
siRNA, the stimulus effect on cell proliferation and the in-
hibitory effect on differentiation and migration which miR-
125b inhibitors bring about was weakened (Figure 8).
Hence, our data support the idea that Nestin as a down-
stream target of miR-125b was implicated in NS/PCs activ-
ities, such as proliferation, differentiation and migration.
Discussion
It is well known that NS/PCs contribute to the neuro-
genesis of the central nervous system. During central
nervous system development in vertebrates, neural stem
cell fate are strictly controlled under regional and tem-
poral manners [15]. Besides the discovery of NS/PCs in
the embryo, recent studies have substantially demon-
strated that NS/PCs continue to reside in the adult ner-
vous system such as hippocampus, the subventricular
zone (SVZ), and in some non-neurogenic regions, in-
cluding spinal cord [1,16]. NS/PCs persist throughout
adult life in nervous system in order to replace the ma-
ture cells that are lost to turnover, injury, or disease. In
response to CNS injuries, NS/PCs can migrate to areasFigure 7 MiR-125b enhanced the mobility ability of NS/PCs cells using
72h transfection. Quantitation and representative photomicrographs showing
All experiments were repeated three times. * P < 0.05 vs. ctr.of injury and differentiate into neuronal and glial cell
types, thus are likely to contribute to the repair of
damaged tissue. Therefore, unraveling the mechanisms
of cellular processes in NS/PCs will provide insights into
both basic neurosciences and clinical applications of
stem cell-based cell replacement therapies.
Although it is well established that NS/PCs have the
potential to cure many diseases, the molecular basis of
this process, particularly the role of miRNAs, remains
largely unknown. MiRNAs are a class of small RNA reg-
ulators that are involved in numerous cellular processes,
including development, proliferation, differentiation, and
plasticity. Emerging evidence has shown that the process
of neural stem cell self-renewal, fate specification and
migration can be regulated by miRNA [17]. As men-
tioned above, there is growing evidence to suggest a role
for miR-125b during neuronal differentiation. In our
study we first quantified the relative expression levels of
miR-125b during neural differentiation. It is likely that
the distinct temporal expression patterns of miR-125b
reflect its specific roles in coordinating gene expression
profiles that characterize neural cell fate determination.
Real-time PCR analyses indicated that miR-125b is sig-
nificantly up-regulated during the differentiation of NS/
PCs. Our study presented here revealed that the inhib-
ition of Nestin expression by miR-125b provides double
insurance to inhibit NS/PCs proliferation when miR-transwell migration assay. Migration assays were performed after
that miR-125b promote cell migration in NS/PCs. Bars show mean±SD.
Figure 8 MiR-125b regulates NS/PCs activities by targeting Nestin. (A) The Brdu incorpation assay indicated that overexpress Nestin may
rescue the inhibitory effect on proliferation which miR-125b mimics bring about. Also, the Nestin siRNA may decrease the stimulus effect on
proliferation which miR-125b inhibitors bring about. (B-F) The immunofulorescence results indicated that overexpress Nestin may rescue the
stimulus effect on NS/PCs differentiation which miR-125b mimics bring about. Also, the Nestin siRNA may weaken the inhibitory effect on NS/PCs
differentiation which MiR-125b inhibitors bring about. (B) Nestin, (C) Sox2, (D) Vimentin, (E) Map2, (F) Tuj1. (G) The migration assay indicated that
overexpress Nestin may rescue the stimulus effect on NS/PCs migration which miR-125b mimics bring about. Also, the Nestin siRNA may weaken
the inhibitory effect on NS/PCs migration which miR-125b inhibitors bring about. Bars show mean ± SD. All experiments were repeated three
times. * P < 0.05 vs. ctr, ** P < 0.01 vs. ctr.
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over, our results suggested that miR-125b promote mi-
gration during the early differentiation of NS/PCs.
The functions of animal miRNAs may be elucidated
through their targeted genes. To gain a better under-
standing the role of miR-125b involved in regulating
wide array of cellular processes in NS/PCs, it is neces-
sary to identify its target genes. A single miRNA can
recognize hundreds of targets. However, one or two of
these target genes may be more important targets in
specific cellular context [18]. Data from computational
analyses suggest that Nestin may be regulated by miR-
125b. As a widely employed marker of multipotent NS/
PCs, Nestin is important for the proper survival and self-renewal of NS/PCs. Numerous in vivo and in vitro studies
now rely on Nestin expression to track the proliferation,
migration and differentiation of NS/PCs [13]. Computer
analysis predicted that miR-125b had partial sequence
complementarity within the 3’-UTR region of the Nestin
mRNA. Using a luciferase assay, we showed that miR-
125b directly target Nestin through binding a specific site
in its 3’-UTR in NS/PCs. Since miRNAs have been shown
to regulate gene expression through both translational at-
tenuation and mRNA degradation. Both real-time PCR
and western blot data suggests that miR-125b could re-
press Nestin expression at both the mRNA and protein
levels via directly binding to its 3'-UTR. In line with previ-
ous report, we detected the expression of Nestin is high in
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In contrast, the level of miR-125b is increased significantly
upon differentiation. In this case, Nestin is preferentially
expressed at high levels when the targeting miRNA expres-
sion is low. The expression of this target is down-regulated
as miR-125b accumulates. Taken together, we identified
Nestin as a target of miR-125b in NS/PCs by using a bio-
informatics approach and experimental validation.
It has previously been reported that miR-125b is a
positive regulator of differentiation of human neural
progenitor ReNcell VM (RVM) cells [19], but the under-
lying mechanism of how it regulates proliferation is not
known. Accumulating evidence has indicated that Nestin
may actively functions in cell growth or proliferation of
different types of neural stem cells. The specific interfer-
ing role of Nestin siRNAs was in vitro identified on cell
growth of C6 astrocytoma cells, suggesting that siRNA-
induced suppression of central neural system tumor cell
growth [19]. To support the hypothesis that the effect of
miR-125b on cellular process is mediated largely through
Nestin, we also knocked down Nestin expression in NS/
PCs using its sequence-spcific siRNA. By using BrdU in-
corporation assays, we demonstrated that overexpression
of miR-125b led to dramatically reduced NS/PCs prolif-
eration in line with the results of Nestin siRNA-treated
cells, indicating that miR-125b inhibit NS/PCs prolifera-
tion by targeting Nestin.
Using immunostaining for the neural marker, we evalu-
ated the effect of miR-125b on neural differentiation poten-
tial of NS/PCs. Overexpression of miR-125b resulted in the
percentage of Tuj1 and Map-2 positive cells increased,
whereas that of Nestin-positive cells decreased. There was
no difference in the percentage of GFAP positive cells
among all groups (data not shown). This could be
explained by the fact that most NS/PCs were also expressed
glial marker GFAP. In the meantime, decrease of Nestin by
RNAi strikingly accelerated the neural differentiation
process, suggesting that miR-125b promoted differentiation
might be mediated by Nestin. Also, we provided direct evi-
dence that miR-125b is a positive regulator of migration
during early neuronal differentiation of NS/PCs. The results
are in good agreement with previous findings demonstrat-
ing that exogenous miR-125b expression increased migra-
tion of ishikawa cells and abrogating expression of miR-
125b suppressed migration of AN3CA cells in vitro [20].
Previous results implied that Nestin might serve as a scaf-
fold regulating the activity of the Cdk5/p35 signaling com-
plex [21,22]. Cdk5 is involved in the processes of neuronal
differentiation and migration [23,24]. Given that knock-
down of Nestin was sufficient to activate cdk5 anctivity,
miR-125b promote neural differentiation and migration
might via activate cdk5 activity during early neuronal differ-
entiation of NS/PCs. A recent report by Donghyun Park
et al. has shown that the neural stem cells which derivedfrom Nestin knockout mice showed dramatically reduced
self-renewal ability but no overt defects in cell proliferation
or differentiation [13]. We speculated the discrepancy be-
tween our study and their study lies in the NS/PCs isolated
from the embryo at different development stages and differ-
ent tissues. In spite of the results of their study were incon-
sistent with our results, it can be interpreted as the Nestin
have multiple functions at different developmental stages
or in different tissues.
In conclusion, these results support the conclusion
that miR-125b is implicated in regulating its downstream
target genes, Nestin, which play a crucial role in NS/PCs
proliferation, differentiation and migration. In addition,
our study does not exclude the possibility that additional
target genes may also play a role in miR-125b function
in NS/PCs. Cultured NS/PCs hold considerable promise
both in terms of their application to a wide variety of re-
search paradigms and in the development of potential
therapeutic modalities [25]. Several important break-
throughs during recent years have raised a hope that
stem cell-based therapies could be used to restore
function and integrity after acute brain injury and
other disorders of the central nervous system. A bet-
ter understanding of the role exerted by miR-125b in
NS/PCs will contribute to offer promising prospects
for their increasing application in the development of
new cellular therapies in humans.
Conclusions
Our data showed the involvement of miR-125b in the
coordinated regulation of proliferation, differentiation
and migration in NS/PCs. The work also indicated that
miR-125b mediated silencing of Nestin may be involved




Primary neural progenitors were prepared by a modified
version of a published protocol [26]. All animal procedures
were performed in accordance with Chinese Ministry of
Public Health (CMPH) Guide and US National Institute
of Health (NIH) Guide for the care and use of laboratory
animals and was approved by the IACUC Bioethics
Committee (IACUC, Institutional Animal Care and Use
Committee-Bioethics Committee) of the Institute of ge-
netics and developmental biology, Chinese academy of
sciences. Briefly, neural tissue samples were dissected from
the hippocampus of newborn Sprague–Dawley (SD) rat
pups, cells were mechanically isolated by repeated tri-
turation in a serum-free culture media composed of
Dulbecco's modified Eagle's medium (DMEM) and
F12 nutrient (1:1) (Invitrogen, Carlsbad, CA . USA). The
dissociated cells were collected by centrifugation at
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medium containing bFGF (10 ng/ml), EGF (20 ng/ml),
and B27 supplement (Gibco, Invitrogen, Carlsbad, CA.
USA). After culturing for 8 days, neurospheres formed
and the cells were used for following experiments. The
neurospheres were then digested with 0.25% trypsin into
single cell suspension and seeded in poly-D-lysine coated
48-well culture plates at a density of 2 × 104 cells per well.
NS/PCs was resuspended in adhesion medium containing
DMEM, 10% FBS (Gibco, Invitrogen, Carlsbad, CA. USA).
For differentiation experiments, the medium was changed
to the differentiation medium serum-free DMEM (high
glucose) with B27 supplement.
Construction of reporter plasmids and luciferase assay
The full length 3'-UTR of the human Nestin gene and
the fragment containing the putative miR-125b binding
site were amplified from human cDNA and individually
cloned into a modified pGL3-promoter vector (Promega,
Madison, WI, USA). The pGL3 luciferase reporter vector
was modified by adding the restriction sites SpeI, NaeI,
SphI, ApaI and PstI downstream of the coding region of
the firefly luciferase, using PCR amplification with the
following primers: forward/NcoI 5'-CTGCCATGGAA
GACGCCAAAAACATA-3' and reverse/XbaI 5'-TGCTC
TAGACTGCAGGGGCCCGCATGCGCCGGCACTAGT
TTACACGGCGATCTTTCCGC-3'. The full-length 3’-
UTR and the mutated 3’-UTR of Nestin was amplified by
PCR using the primers listed in Table 1. Also, the 3’-UTR
of ACTB was amplified by PCR using the primers listed in
Table 1. The mutated 3’-UTR of Nestin was generated
using site-directed mutagenesis according to the manufac-
turer's protocol. The primers containing the mutation are
listed in Table 1. The site-directed mutagenesis kit (Trans-
Gen Biotech, Beijing, China) was used to generate the mu-
tation in the 3' UTR of the Nestin gene by PCR, using the
full-length 3' UTR of Nestin as the template. All PCR pro-
ducts were digested at the SpeI and SphI sites before clon-
ing into the pGL3-promoter vector.
To assess whether miR-125b could bind to Nestin
mRNA 3' UTR, Hela cells were seeded in 24-well platesTable 1 Primers used to construct luciferase reporter plasmid
Gene name
Nestin 3’UTR Forward/ SpeI: 5'- GGA
(mir-125b sense) Reverse/ SphI:5'- ACATG
Nestin 3’UTR Forward/ SpeI: 5’- GCA
(mir-125b mutated 1 putative binding region) Reverse/ SphI:5'- CACC
Nestin 3’UTR Forward/ SpeI: 5’- TGGC
(mir-125b mutated 2 putative binding region) Reverse/ SphI: 5'- CCGG
ACTB 3’UTR Forward/ SpeI: 5'- GGA
Reverse/ SphI: 5'- ACATin DMEM high-glucose medium. The cells were trans-
fected with 500 ng of wild-type or mutant reporter plas-
mid, 25 ng of Renilla luciferase expression vector, and
miR-125b mimic (10nM) or miR-125b inhibitor (10nM)
or equal amounts of NC, INNC (GenePharma Co., Ltd.,
Shanghai, China) using Lipofectamine 2000™ reagent
(Invitrogen, Carlsbad, CA, USA), according to the man-
ufacturer’s instructions. After 48 h, the cell extract was
obtained, and firefly and Renilla luciferase activities were
measured with the dual-luciferase reporter system (Pro-
mega, Madison, WI, USA) according to the manufac-
turer's instructions. The results were expressed as
relative luciferase activity (Firely LUC/Renilla LUC).
Transient transfections and cell treatments
To perform RNAi experiment, NS/PCs were transfected
with siRNA duplexes when cells reached 80–90% con-
fluency on the day of transfection. Lipofectamine 2000™
reagent was used as the transfection reagent. Three in-
dependent transfection experiments were performed in
triplicate with each construct. Transfection was carried
out after third passage in 6-well plate (Corning Costar,
Cambridge, MA). Twenty-four hours before transfection,
3 × 105 NS/PCs per well were seeded in 6-well plate with
fresh DMEM/F12 without antibiotics, in order to obtain
80–90% confluency on the day of transfection. For trans-
fection, 10 μM siRNA solution were used for each well
according to the siRNA application protocol. The rat
Nestin siRNA contained a pool of three different siRNA
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taining antibiotics was added to the cells.
In rescue experiment, NS/PCs were cotransfected with
the plasmid NES-640-GFP and miR-125b mimics. NS/
PCs were transfected with LipofectamineW LTX with
Plus™ Reagent (life technologies, New York, NY) accord-
ing to the manufacturer’s protocol. For each well of a
Lipofectamine LTX transfection, 2.5 μg of NES-640-GFP
plamid DNA and 10nM of miR-125b mimic were com-
bined with 1.25 μl of Plus reagent (Invitrogen,catalog
number 11514-015) in 500 μl of serum-free media
for 5 min. 5 μl of Lipofectamine LTX (Invitrogen,
catalog number 15338-100) was then added, mixed,
and incubated for an additional 25 min before being
added dropwise to cells. In another group, NS/PCs
were cotransfected with Nestin siRNA and miR-125b
inhibitor, 10 μM Nestin siRNA and 10 nM of miR-
125b mimics were mixed together to perform the
cotransfection experiments. Lipofectamine 2000™ re-
agent (Invitrogen, Carlsbad, CA, USA) was used
according to the manufacturer’s instructions as men-
tioned above.Quantitative real-time PCR
Total RNA was extracted with TRIzol Reagent (Invitro-
gen, Carlsbad, CA, USA). Reverse transcription was per-
formed using SuperScript™ III First-Strand Synthesis
System (Invitrogen, Carlsbad, CA, USA). The primer
sequences used in the experiment were listed in Table 2.
Real-time PCR was performed using SYBRW Green PCR
Master Mix (Roche, Mannheim, Germany) on CFX96™
Real-Time PCR Detection System (Biorad). Samples
were run in triplicates. PCR conditions were 94°C for
3 min followed by 40 cycles of 94°C for 30 s, 60°C for 30
s and 72°C for 30 s, using a melting curve program and
continuous fluorescence measurement. The results are
reported as the relative expression after normalization of
the transcript to glyceraldehyde-3-phosphate dehydro-
genase (GAPDH; endogenous control) using the 2T
–ΔΔC
method [27].Table 2 Primers used in qRT-PCR
Gene symbol Primer s
Nestin (Homo Sapiens) Forward: TGGCAAAGGAGCCTACTCCAAG
Nestin (Rattus Norvegicus) Forward: AGAGAAGCGCTGGAACAGAG; R
Tuj1(Rattus Norvegicus) Forward: AGCAGATGCTGGCCATTCAGAG
Sox2 (Rattus Norvegicus) Forward: AAAGGAGAGAAGTTTGGAGCCC
Vimentin (Rattus Norvegicus) Forward: AGGTGGATCAGCTCACCAATGA
Map2 (Rattus Norvegicus) Forward: GCAGCGCCAATGGATTTCCATAC
Gapdh(Homo Sapiens) Forward: CATGTTCGTCATGGGTGTGAACC
Gapdh(Rattus Norvegicus) Forward: AAGGGCTCATGACCACAGTC; ReMiRNA extraction and TaqMan assay
MiRNAs were extracted using the miRVana extraction
kit (Ambion, Austin,TX, USA) according to the manu-
facturer’s instructions after a phenol-chloroform purifi-
cation step. For quantification of miR-125b, 2 μg total
RNA was reverse-transcribed and amplified by using the
microRNA reverse transcription and detection Kit (Ap-
plied Biosystems, Inc. Foster City, CA) according to the
manufacturer’s specified guidelines. All results were nor-
malized to U6 levels that were detected by using the ABI
miRNA U6 assay kit (Applied Biosystems, Inc. Foster
City, CA). PCRs were normalized with the same test
samples and U6 rRNA-specific primers. Significant dif-
ferences in expression were determined using the Stu-
dent’s t-test and considered significant if P < 0.05.
Proliferation assay
The detection of cell proliferation has employed the
incorporation of the thymidine analog BrdU (Bromodeox-
yuridine, 5-bromo-2'-deoxyuridine) during DNA synthe-
sis, followed by detection with an anti-Brdu antibody [28].
In our study, experimental groups of cells were left in the
cell media pulse-labeled with 10 μM BrdU (B5002, Sigma-
Aldrich, St. Louis, MO) for 16 hours and stained with an
anti-BrdU antibody (B2531, Sigma-Aldrich, St. Louis,
MO) [29]. For the BrdU staining, the cells were fixed with
4% paraformaldehyde in phosphate buffer at room tem-
perature for 30 min and then washed and stored in PBS.
All experiments were performed on a minimum of three
litters in triplicate.
Western blotting
NS/PCs were lysed with RIPA buffer (Sigma-Aldrich, St.
Louis, MO) supplemented with proteinase inhibitor
cocktail (Sigma-Aldrich, St. Louis, MO) for 30 min on
ice to prepare the whole-cell lysates. The cell lysates
were then clarified by centrifugation at 12,000 × g for
30 min. The protein concentration was measured by
Bradford assay. Equivalent quantity protein lysates were
electrophoresed in 10% SDS-ployacrylamide gel, andequence(5’-3’) Product size (bp)
AA ; Reverse: ATCGGGATTCAGCTGACTTAGCCT 111
everse: AGGTGTCTGCAACCGAGAGT 234
TA; Reverse: TAAACTGCTCGGAGATGCGCTTGA 174
GA; Reverse: GGGCGAAGTGCAATTGGGATGAAA 113
CA ; Reverse: TCAAGGTCAAGACGTGCCAGAGAA 184
A ; Reverse: TCCGTTGATCCCGTTCTCTTTGGT 104
A; Reverse: AGTGATGGCATGGACTGTGGTCAT 160
verse: GTGAGCTTCCCATTCAGCTC 169
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(Amershame, GE, Buckinghamshire, UK). The mem-
brane was block in tris-buffered saline (TBS) containing
10% nonfat milk and 0.05% tween-20 for 2 h at the room
temperature. Primary antibodies were incubated over-
night at 4°C, and primary antibodies included anti-
Nestin (SC-21248, Santa Cruz Biotechnology Inc.,
Santa Cruz, CA), and anti-alpha-tubulin (Sigma-
Aldrich, St. Louis, MO). The HRP labeled secondary
antibody (PIERCE, Rockford, USA) was used for 2 h
at the room temperature at the dilution of 1:5000.
Immunofluorescence
Four days after transfection, NS/PCs cells were fixed in
cold 4% PFA for 30 min, followed by three washes with
phosphate-buffered saline (PBS). After a 1-h blocking
with 0.2% Triton X-100 and 3% goat serum in PBS, the
cells were incubated with primary antibodies at
37°C for 2 hours. The primary antibodies used in this
study include Nestin (1:400; MAB353, Millipore) , Brdu
(1:500; B2531, Sigma ), Tuj1 (1:500,05-549, Upstate),
Sox2 (1:100; 481400, Life technologies ), Map-2 (1:400;
M1406, Sigma), Vimentin (1:100; V6630, Sigma) over-
night at 4°C . All primary antibodies are diluted in the
blocking buffer (1% goat serum in PBS) after which cells
are washed three times with PBS, and incubated for 1 h
at room temperature with secondary antibodies. The
secondary antibodies are anti-mouse IgG FITC antibody
(1:200, St. Louis, MO, USA) and anti-rabbit IgG FITC
antibody (1:1000, St. Louis, MO, USA) diluted in block-
ing buffer. Nuclei are counter-stained with Hochest
33342 (1:500; 94403, St. Louis, MO, USA). The stained
cells are washed three times with PBS and visualized on
Zeiss 200 inverted fluorescent microscope (Carl Zeiss,
Jena, Germany). The number of immunostained cells
was counted in each of three random fields per well and
the fluorescence images were selected randomly. Quanti-
fication of the immunofluorescence signal was per-
formed by measuring average intensity in individual cells
according to the Image J software manual.
Transwell migration assay
Migration assays were carried out in a 24-well transwell
using polycarbonate membranes with 8-μm pores (Corn-
ing Costar, Cambridge, MA). For adherent NS/PC cells
porous membrane was coated by collagen. NS/PCs cells
at a density of 1 × 106 cells/ml in 100 μl of medium
(DMEM/F12) were placed in the upper chamber of the
transwell assembly. The lower chamber contained 600 μl of
medium (DMEM/F12 + 1% fetal bovine serum+ 100 ng/ml
SCF) [30]. After incubation at 37°C and 5% CO2 for 12
hours, the upper surface of the membrane was scraped
gently to remove non-migrating cells and washed with
phosphate-buffered saline. The membrane was then fixedin 4% paraformaldehyde for 15 minutes and then stained
with hematoxylin and eosin. The number of migrating
cells was determined by counting five random fields per
well under the microscope at × 40 magnification. Assays
were performed in duplicates and data was expressed as
percent migration with control.
Statistical analysis
All values are expressed as mean ± s.d. Statistical signifi-
cance (defined as P < 0.05) was evaluated with SPSS soft-
ware (SPSS GmbH, Munich, Germany) using the
Student's t-test and ANOVA .
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